These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
451 related items for PubMed ID: 15471652
1. Considerations of healthcare professionals in medical decision-making about treatment for clinical end-stage cancer patients. van Leeuwen AF, Voogt E, Visser A, van der Rijt CC, van der Heide A. J Pain Symptom Manage; 2004 Oct; 28(4):351-5. PubMed ID: 15471652 [Abstract] [Full Text] [Related]
2. Requests to forgo potentially life-prolonging treatment and to hasten death in terminally ill cancer patients: a prospective study. Georges JJ, Onwuteaka-Philipsen BD, van der Heide A, van der Wal G, van der Maas PJ. J Pain Symptom Manage; 2006 Feb; 31(2):100-10. PubMed ID: 16488343 [Abstract] [Full Text] [Related]
3. [Providing or withholding treatment: the role of the patient's wish and priorities in palliative care]. Baberg HT, Kielstein R, de Zeeuw J, Sass HM. Dtsch Med Wochenschr; 2002 Aug 16; 127(33):1690-4. PubMed ID: 12183801 [Abstract] [Full Text] [Related]
4. Decision making by parents and healthcare professionals when considering continued care for pediatric patients with cancer. Hinds PS, Oakes L, Furman W, Foppiano P, Olson MS, Quargnenti A, Gattuso J, Powell B, Srivastava DK, Jayawardene D, Sandlund JT, Strong C. Oncol Nurs Forum; 1997 Oct 16; 24(9):1523-8. PubMed ID: 9348593 [Abstract] [Full Text] [Related]
5. End-of-life decisions in Australian medical practice. Kuhse H, Singer P, Baume P, Clark M, Rickard M. Med J Aust; 1997 Feb 17; 166(4):191-6. PubMed ID: 9066548 [Abstract] [Full Text] [Related]
6. [No conspicuous changes in the practice of medical end-of-life decision-making for neonates and infants in the Netherlands in 2001 as compared to 1995]. Vrakking AM, van der Heide A, Onwuteaka-Philipsen BD, Keij-Deerenberg IM, van der Maas PJ, van der Wal G. Ned Tijdschr Geneeskd; 2005 Sep 10; 149(37):2047-51. PubMed ID: 16184946 [Abstract] [Full Text] [Related]
7. Forgoing treatment at the end of life in 6 European countries. Bosshard G, Nilstun T, Bilsen J, Norup M, Miccinesi G, van Delden JJ, Faisst K, van der Heide A, European End-of-Life Consortium. Arch Intern Med; 2005 Feb 28; 165(4):401-7. PubMed ID: 15738368 [Abstract] [Full Text] [Related]
8. Euthanasia and other medical decisions concerning the end of life. An investigation performed upon request of the Commission of Inquiry into the Medical Practice concerning Euthanasia. van der Maas PJ, van Delden JJ, Pijnenborg L. Health Policy; 1992 Sep 28; 21(1-2):vi-x, 1-262. PubMed ID: 10145729 [No Abstract] [Full Text] [Related]
9. Influence of the metropolitan environment on end-of-life decisions: A population-based study of end-of-life decision-making in the Brussels metropolitan region and non-metropolitan Flanders. Cohen J, Chambaere K, Bilsen J, Houttekier D, Mortier F, Deliens L. Health Place; 2010 Sep 28; 16(5):784-93. PubMed ID: 20430683 [Abstract] [Full Text] [Related]
11. Medical end-of-life decisions in children in Flanders, Belgium: a population-based postmortem survey. Pousset G, Bilsen J, Cohen J, Chambaere K, Deliens L, Mortier F. Arch Pediatr Adolesc Med; 2010 Jun 28; 164(6):547-53. PubMed ID: 20530305 [Abstract] [Full Text] [Related]
12. Trends and determinants of end-of-life practices in ALS in the Netherlands. Maessen M, Veldink JH, Onwuteaka-Philipsen BD, de Vries JM, Wokke JH, van der Wal G, van den Berg LH. Neurology; 2009 Sep 22; 73(12):954-61. PubMed ID: 19770471 [Abstract] [Full Text] [Related]
13. Drugs used to alleviate symptoms with life shortening as a possible side effect: end-of-life care in six European countries. Bilsen J, Norup M, Deliens L, Miccinesi G, van der Wal G, Löfmark R, Faisst K, van der Heide A, EURELD Consortium. J Pain Symptom Manage; 2006 Feb 22; 31(2):111-21. PubMed ID: 16488344 [Abstract] [Full Text] [Related]
14. Discrepancies among patients, family members, and physicians in Korea in terms of values regarding the withholding of treatment from patients with terminal malignancies. Oh DY, Kim JE, Lee CH, Lim JS, Jung KH, Heo DS, Bang YJ, Kim NK. Cancer; 2004 May 01; 100(9):1961-6. PubMed ID: 15112278 [Abstract] [Full Text] [Related]
15. Forgoing life-sustaining treatments: comparison of attitudes between Israeli and North American intensive care healthcare professionals. Soudry E, Sprung CL, Levin PD, Grunfeld GB, Einav S. Isr Med Assoc J; 2003 Nov 01; 5(11):770-4. PubMed ID: 14650099 [Abstract] [Full Text] [Related]
16. [Withholding and withdrawing therapy--how does the physician make a decision?]. Neumann P. Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 May 01; 44(5):380-4. PubMed ID: 19440947 [Abstract] [Full Text] [Related]
17. [Insight into end-of-life decisions in newborns in Flanders, Belgium]. Verhagen AA. Ned Tijdschr Geneeskd; 2006 Feb 18; 150(7):355-7. PubMed ID: 16523796 [Abstract] [Full Text] [Related]
18. Physician medical decision-making at the end of life in newborns: insight into implementation at 2 Dutch centers. Verhagen AA, van der Hoeven MA, van Meerveld RC, Sauer PJ. Pediatrics; 2007 Jul 18; 120(1):e20-8. PubMed ID: 17606544 [Abstract] [Full Text] [Related]
19. Physician end-of-life decision-making in newborns in a less developed health care setting: insight in considerations and implementation. Verhagen AA, Spijkerman J, Muskiet FD, Sauer PJ. Acta Paediatr; 2007 Oct 18; 96(10):1437-40. PubMed ID: 17714536 [Abstract] [Full Text] [Related]
20. Nurses' involvement in end-of-life decisions. de Veer AJ, Francke AL, Poortvliet EP. Cancer Nurs; 2008 Oct 18; 31(3):222-8. PubMed ID: 18453879 [Abstract] [Full Text] [Related] Page: [Next] [New Search]